Trending...
- Australian Aboriginal Cultural Immersions and First Nations Workshops
- Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
- Men's Health Network Highlights Major 2025 Achievements & Launches New Donation Platform For Greater Impact
TRAVERSE CITY, Mich. & TORONTO - PennZone -- The DG Meditech today announced the appointment of Davis Gravelsins as Chief Executive Officer, US Operations. Previously working as Senior Liaison Digital Transition - Healthcare on projects in the Baltic and in the E.U., Mr. Gravelsins will now be heading up DG Meditech's service expansion into North and South American geographies.
Founded in Daugavpils, Latvia in 1989 as Derzins Glochsteinbacher Medicīnas Programmatūras Risinājumu Korporācija, (DGMPR Korp.) the company rebranded in 2020 as DG Meditech to expand into markets outside of Europe, where is known for its large service offering of digital transformation services, working with government and state-run corporate clientele in acute and long-term care, as well as in medical, therapeutic, homecare and behavioral areas.
Eying new international opportunities, the company opened offices in Traverse City, Michigan and Toronto, Canada prior to the onset of Covid-19, and has since built agile consulting teams in each city. These teams of consist of consultants, analysts, compliance experts and finance personnel who are working under Mr. Gravelsins to finance and manage new North American investment opportunities for DG Meditech's European clients.
More on The PennZone
Operating as DGMPR Korp. and now as DG Meditech, the company has provided digital transformation services including finance, purchasing and software solution optimization expertise for dozens of clients for over three decades, deploying some of the first EHR and IMS solutions in European state-run and private healthcare.
The company's clients include ACOs, hospitals, home care groups, Skilled Nursing Facilities, senior living organizations, along with many long-term care facilities and their government funding organizations.
"I am very excited to be heading up our expansion from Europe to the Americas. Many of our clients are well down the transformation path, and are now actively pursuing management and purchasing opportunities in Canada, the USA, Mexico, Brazil and Argentina. We are pleased to be part of this global drive to expand operations while digitally transforming client's portfolios." Said Mr. Gravelsins.
- 30 –
For more information, please contact us:
Toronto, Canada Office: Mr. D. Gravelsins
davis.gravelsins@dgmeditech.com
Travers City Office: Mr. J. Anson
janson@dgmeditech.com – 705-943-8225
Founded in Daugavpils, Latvia in 1989 as Derzins Glochsteinbacher Medicīnas Programmatūras Risinājumu Korporācija, (DGMPR Korp.) the company rebranded in 2020 as DG Meditech to expand into markets outside of Europe, where is known for its large service offering of digital transformation services, working with government and state-run corporate clientele in acute and long-term care, as well as in medical, therapeutic, homecare and behavioral areas.
Eying new international opportunities, the company opened offices in Traverse City, Michigan and Toronto, Canada prior to the onset of Covid-19, and has since built agile consulting teams in each city. These teams of consist of consultants, analysts, compliance experts and finance personnel who are working under Mr. Gravelsins to finance and manage new North American investment opportunities for DG Meditech's European clients.
More on The PennZone
- Tickeron Launches Next-Gen AI Corridor Bots: Consistent Exits for Stocks and ETFs
- From Cheer to Courtroom: The Hidden Legal Risks in Your Holiday Eggnog
- Controversial Vegan Turns Rapper Launches First Song, "Psychopathic Tendencies."
- Inside the Fight for Affordable Housing: Avery Headley Joins Terran Lamp for a Candid Bronx Leadership Conversation
- Canterbury Hotel Group Announces the Opening of the TownePlace Suites by Marriott Portland Airport
Operating as DGMPR Korp. and now as DG Meditech, the company has provided digital transformation services including finance, purchasing and software solution optimization expertise for dozens of clients for over three decades, deploying some of the first EHR and IMS solutions in European state-run and private healthcare.
The company's clients include ACOs, hospitals, home care groups, Skilled Nursing Facilities, senior living organizations, along with many long-term care facilities and their government funding organizations.
"I am very excited to be heading up our expansion from Europe to the Americas. Many of our clients are well down the transformation path, and are now actively pursuing management and purchasing opportunities in Canada, the USA, Mexico, Brazil and Argentina. We are pleased to be part of this global drive to expand operations while digitally transforming client's portfolios." Said Mr. Gravelsins.
- 30 –
For more information, please contact us:
Toronto, Canada Office: Mr. D. Gravelsins
davis.gravelsins@dgmeditech.com
Travers City Office: Mr. J. Anson
janson@dgmeditech.com – 705-943-8225
Source: DGMeditech
0 Comments
Latest on The PennZone
- BRAG Hosts Holiday Benefit — Awards 10 Student Scholarships & Honors Timberland with the Corporate Impact Award
- FittingPros Launches Industry's First Data-Driven Golf Club Fitting Directory
- African American Genealogy Group Launches 2025 Raffle Fundraiser to Support Legacy Research
- Take Control of Your Color Matching with Boston Industrial Solutions' Newly Expanded Natron® UVPX Series Ink Colors
- "Dr. Vincent Michael Malfitano Expands Monterey–Sicily Cultural Diplomacy With Major International Media Engagement"
- Kaufman Development Breaks Ground on Detroit Micro Data Center, Expanding Its National AI Platform
- Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
- $80M+ Backlog as Florida Statewide Contract, Federal Wins, and Strategic Alliance Fuel Next Phase of AI-Driven Cybersecurity Growth: Cycurion $CYCU
- High-Conviction CNS Disruptor Aiming to Transform Suicidal Depression, Ketamine Therapeutics, and TMS - Reaching Millions by 2030
- Top10Christmas.co.uk Releases the UK Christmas Toy Trends 2025 Report
- Talagat Business Academy Announces Joint Certificate Program With The University of Chicago Booth School of Business
- LocaXion and Asseco CEIT Announce First-to-Market RTLS-Driven Digital Twin Platform for Healthcare, Manufacturing, and Logistics
- Slotozilla Launches New Report on How AI Is Reshaping Careers and Society
- OKAVA Pharmaceuticals Announces First Cat Dosed in MEOW-1 Study of OKV-119, the World's First Clinical-Stage GLP-1 Weight-Loss Therapy for Pets
- Explosive Growth in U.S. Cryptocurrency Cloud Mining Sets The Stage for New Platform Launch with Daily Rewards in a Transparent Revenue-Share Model
- Qtex Cierra Ronda de $7 Millones para Estandarizar la Banca Transfronteriza en los Mercados Emergentes de Latinoamérica
- Ring in the Season with Free Holiday Jazz from The Jazz Sanctuary
- America's Most Festive Garages Wanted for Garage.com's 2025 Holiday Contest
- FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough
- BEC Technologies Expands MX-220 5G Industrial Router Series for Edge Connectivity
